Bard Encor Enspire Breast Biopsy System

Public supplier signals are visible here. Send an inquiry when the listing looks commercially fit.
Product Details
The Bard Encor Enspire represents a significant advancement in the field of vacuum-assisted breast biopsy (VABB), building upon the legacy of earlier Encor systems. It is engineered to provide clinicians with a reliable and efficient platform for acquiring high-quality tissue samples for definitive diagnostic analysis.
This system is designed to be a comprehensive solution for minimally invasive breast biopsies, serving as a critical alternative to open surgical procedures. Its core function is to use vacuum assistance and a rotating cutting needle to collect tissue specimens, often under stereotactic, ultrasound, or MRI guidance. The Encor Enspire is recognized for its intuitive operation and consistent performance in demanding clinical environments.
- Procedural Efficiency: Designed with a straightforward user interface and streamlined workflow to support high-volume breast centers.
- Tissue Quality: Aims to acquire robust, contiguous tissue samples essential for accurate histopathological assessment.
- Versatile Application: Intended for use across various imaging modalities, providing flexibility for interventional radiologists and surgeons.
For procurement managers and clinical department heads, the Bard Encor Enspire is a workhorse system that can anchor a breast biopsy program. Its established reputation for reliability makes it a sound consideration for facilities looking to upgrade or expand their diagnostic capabilities in women's health.
More from ALM International Inc









More in Biopsy Unit




Related editorial coverage
Ultrasound Transducer Common Failure Modes: How to Diagnose, Repair, or Replace
Ultrasound probe image problems? Diagnose lens delamination, oil leaks, cable damage & element dropout. Repair vs replace framework + find repair services on MedTrade.
AI Medical Imaging 2026: What the Clinical Data Actually Says
A data-driven look at AI radiology in 2026: the largest RCT ever conducted, why models crash across populations, and the ROI gap no one talks about.